Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620308 · ClinicalTrials.gov registry record · Phase 1
CD-NP in Subjects With Stable Chronic Heart Failure
A Phase 1 study of Stable Chronic Heart Failure, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT00620308 is a Phase 1 study of Stable Chronic Heart Failure that has completed, run by Mayo Clinic. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00620308, a Phase 1 study of Stable Chronic Heart Failure, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This human physiologic study will evaluate the effects of a new drug called CD-NP in individuals with stable chronic heart failure, with a focus on evaluating responses of the kidneys and the hormonal system.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG CD-NP
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00620308
The ClinicalTrials.gov registry entry for NCT00620308 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stable Chronic Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00620308 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00620308 about?
NCT00620308 is a clinical study titled "CD-NP in Subjects With Stable Chronic Heart Failure". This human physiologic study will evaluate the effects of a new drug called CD-NP in individuals with stable chronic heart failure, with a focus on evaluating responses of the kidneys and the hormonal system.
What is the current status of trial NCT00620308?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2008-06. Estimated completion is 2012-02.
What conditions does trial NCT00620308 study?
This clinical trial studies the following conditions: Stable Chronic Heart Failure.
What interventions are being tested in trial NCT00620308?
The interventions under investigation include: Placebo (DRUG), CD-NP (DRUG).
Who is sponsoring clinical trial NCT00620308?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00620308 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.